Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q3 2024 (September 30)1holders −17
0new positions
18sold out
$0.29avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, down 17 from Q2 2024. 0 opened new positions and 18 sold out. The largest holder was IFP Advisors, Inc ($2).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468202
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 18 | $720K |
All 13F filers, Q2 2024 → Q3 2024: 1,941,659 shares sold, net −1,941,659 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | No change | 7 | $2 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.